










































American Journal Of Biomedical Science & Pharmaceutical Innovation 51 https://theusajournals.com/index.php/ajbspi 

 
 

 VOLUME Vol.05 Issue04 2025 

PAGE NO. 51-55 

DOI 10.37547/ajbspi/Volume05Issue04-12 

 
 
 
 

Analysis of The Sale of Adaptogenic Drugs in The 

Republic of Uzbekistan 
 

Djalilova Hanifa Mirkomil kizi 

Tashkent Research Institute of Vaccines and Serums, Research Fellow, Uzbekistan 

 

Ashurov Abdurahman Akbaraliyevich 

Tashkent Research Institute of Vaccines and Serums, Director, KfN, Uzbekistan 

 

Kambarov Khusan Jahangirovich 

Tashkent Pharmaceutical Institute, PhD., Uzbekistan 

 

 

Received: 28 February 2025; Accepted: 29 March 2025; Published: 30 April 2025 

 

Abstract: This article provides an in-depth analysis of the sales of adaptogenic drugs in the pharmaceutical market 
of Uzbekistan for the period 2021-2024. Key trends, changes in the market structure, the dynamics of the range 
of pharmaceutical forms, pricing policy, and further development prospects were studied. Special attention was 
paid to import dependence, localization of production, and the introduction of new technologies. The presented 
data are visualized in the form of diagrams and graphs. 

 

Keywords: Adaptogenic drugs, pharmaceutical market, import substitution, dosage forms, local production, 
marketing strategy, innovation, state support. 

 

Introduction: Adaptogenic drugs contribute to 
increasing the body's resistance to physical, mental, 
and emotional stress. They are widely used in medicine 
to correct conditions caused by stress, fatigue, and 
decreased immunity. [1] In Uzbekistan, the adaptogen 
market has long been dependent on imported supplies, 
which has affected their availability and cost. However, 
in recent years, there has been a trend towards 
developing local production, which contributes to 
reducing dependence on foreign manufacturers and 
increasing the availability of medicines for the 
population. [2] This work is aimed at studying the 
dynamics of the adaptogenic drugs market in the 
country for the period 2021-2024 

Relevance. The relevance of this topic lies in several key 
aspects: 

1. Growing demand for adaptogenic drugs - the 
population is increasingly favoring natural and safe 
methods of maintaining health, which increases 
interest in adaptogens. 

2. Import dependence and the need for local 
production - reducing the share of imported drugs and 
developing the national pharmaceutical sector will help 
improve the availability and reduce the cost of 
adaptogens for consumers. [3] 

3. State support for pharmaceuticals - Uzbekistan is 
experiencing active development of the 
pharmaceutical industry, including import substitution 
programs and investments in local production. Decree 
of the President of the Republic of Uzbekistan Sh.M. 
Mirziyoyev. PF-13 January 28, 2024:  

To accelerate the development of the pharmaceutical 
industry, significantly increase the volume of attracted 
investments and exports, as well as ensure the 
availability of high-quality, safe, and effective 
medicines for the population. [4] 

4. Export potential - the expansion of the Uzbek 
pharmaceutical market to neighboring countries 
(Kazakhstan, Tajikistan, Turkmenistan) opens up new 
business opportunities. 

 

https://doi.org/10.37547/ajbspi/Volume05Issue04-12
https://doi.org/10.37547/ajbspi/Volume05Issue04-12
https://doi.org/10.37547/ajbspi/Volume05Issue04-12
https://doi.org/10.37547/ajbspi/Volume05Issue04-12


American Journal of Applied Science and Technology 52 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

5. The change in consumer preferences - the growing 
interest in tea mixtures and dry extracts - confirms the 
trend towards natural dosage forms. 

METHODOLOGY 

The study is based on the analysis of the State Register 
of Medicines, open sources, as well as marketing 
reports of large pharmaceutical companies. Content 
analysis, comparative analysis, and structural and 
dynamic analysis of market indicators were used. 

Additionally, interviews were conducted with 
representatives of pharmaceutical companies, industry 

experts, and doctors who use adaptogenic drugs in 
their practice. Based on the obtained data, market 
development forecasts were made. 

According to BusinesStat, the production of medicines 
in Uzbekistan increased by 3% in 2023 and reached 565 
million packages. This trend has also affected the 
adaptogen segment, which is experiencing a steady 
increase in demand due to the growing interest in 
natural preparations. 

 

 

 

 

Main market trends (2021-2024) 

Import dependency and local production 

• In 2021-2023, imported drugs accounted for 90-91% 
of the market. 

• In 2024, dependency decreased to 76%, which 
indicates an increase in the share of local production. 

• Main supplier countries: 

2021-2023: Pakistan (59.1%), India (8.8%), China 
(14.2%), Germany (7%), Bulgaria (7%), USA (4.8%). 

o 2024: India (19%), China (14.2%), Pakistan (14.2%),  

 

Russia (14.2%), Turkey (4.8%), USA (4.8%). 

The market also features foreign brands, such as: 

- Imperial Adaptogen (Paradise Herbs) - a complex of 
concentrated adaptogens. 

- Solgar Rhodiola Root Extract is a preparation based on 
pink radish. 

Imported drugs occupy a significant portion of the 
market, but their cost is higher compared to domestic 
analogues. 

  

0 10 20 30 40 50

Syrups

tablets

capsules

dragee

granules

tea mixtures

dry extrakt

MARKET SHARE % 

dynamics of the range medicinal 
forms of adaptogens

2021-2023

2024

0 10 20 30 40 50 60 70 80 90 100

local

imported

RELATIVE VALUE (UNIT)

comparison of price adaptogenic 
drugs(2021 and 2024)

2021

2024



American Journal of Applied Science and Technology 53 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

The share of local producers increased from 4% in 2021 
to 9.8% in 2024. 

• The development of local production is due to 
government support, the introduction of subsidies for 
pharmaceutical companies, and investments in the 
development of pharmaceutical production. 

Price policy 

• In 2021, imported drugs were 4-7 times more 
expensive than local ones. 

• In 2024, the price gap has decreased, but imported 
medicines remain more expensive than their local 
counterparts. 

• The average cost of imported adaptogens is 70,000 
UZS, while local analogues cost 30,000 UZS. 

• The highest price increase was recorded in the plant 
adaptogen segment, which is associated with an 
increase in raw material costs and logistics costs. 

  

 

Dynamics of the range of medicinal forms 

Dosage form 2021-2023 (market share) 2024 (market 
share) 

Syrups              45%              23.8% 

Tablets             21.4%           21.4% 

Capsules          16.6%           16.6% 

Dragee             14.2%           14.2% 

Granules           9.5%             9.5% 

Tea mixtures    - 7.1% 

Dry extracts     7.1%             7.1% 

 

• The proportion of syrups decreased by 21.2%, which 
may be related to increased interest in more 
convenient forms of administration, such as tablets and 
capsules. 

• The popularity of tea and dry extracts is growing,  

which is due to increased interest in natural medicine. 

0

5

10

15

20

25

30

35

40

45

Russia China USA Other

M
A

R
K

ET
 S

H
A

R
E 

(%
)

COUNTRY OF ORIGIN

structure of import adaptogens to Uzbeistan

0 50000 100000 150000 200000 250000 300000

Tribestan

Prolarge

Ginsomin Eva

Velson

Viraton

Minorishan

Vivabon

Ginseng tincture

AVERAGE PRICT (UZS)

Top-selling adaptogenic drugs in 
Uzbekistan (2021-2024)



American Journal of Applied Science and Technology 54 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

  

Pharmaceutical sector development prospects 

1. Expansion of local production 

o Development of adaptogens based on local plant raw 
materials. 

o Increasing investments in the pharmaceutical 
industry. 

o Improvement of production technological processes. 

2. Stimulation of import substitution 

o Support for domestic producers at the state level. 

o Reducing the tax burden for local pharmaceutical 
companies. 

3. Development of export potential 

o Access to the markets of neighboring countries such 
as Kazakhstan, Tajikistan, and Turkmenistan. 

o Promotion of Uzbek adaptogens at international 

pharmaceutical exhibitions. 

4. Improvement of marketing strategies 

Introduction of loyalty programs for consumers. 

o Conducting information campaigns about the 
benefits of adaptogens. 

Forecast 

It is expected that by 2026, the adaptogen market in 
Uzbekistan will grow by another 10-15%, which will 
contribute to: 

- Increased interest in natural remedies. 

- Expanding the range of local producers. 

- State initiatives for the development of the 
pharmaceutical sector. 

 

 

 

Graph 4: Growth forecast of the adaptogen market in Uzbekistan (2024-2026) 

The market for adaptogenic drugs in Uzbekistan is 
showing positive dynamics due to the demand for 
natural products. Local producers are gradually 
strengthening their positions, but imports remain a 

significant part of the segment. In the future, we can 
expect to increase production and expand the range, 
which will lead to a decrease in dependence on foreign 
supplies and an increase in the availability of 

0

20

40

60

80

100

2021 2022 2023 2024
YEAR

Dynamics of import and production of adaptogens 
in Uzbekistan

import(%)

local production(%)

580

590

600

610

620

630

2024 2025 2026P
R

O
D

U
C

TI
O

N
 V

O
LU

M
E 

(M
IL

LI
O

N
 

P
A

SK
A

G
ES

)

YEAR

Adaptogens Market Growth Forecast (2024 -2026)



American Journal of Applied Science and Technology 55 https://theusajournals.com/index.php/ajast 

American Journal of Applied Science and Technology (ISSN: 2771-2745) 
 

 

adaptogens for the population. 

CONCLUSION 

During the period 2021-2024, the adaptogenic drug 
market in Uzbekistan demonstrated a stable trend 
towards increased local production and reduced 
import dependence. However, the share of imported 
drugs remains high (76%), and the price difference 
between local and foreign adaptogens persists. For 
further market development, it is necessary to actively 
stimulate local production, provide state support, and 
introduce innovations to enhance the competitiveness 
of Uzbek manufacturers. 

REFERENCES 

Kurkin V.A., Petrukhina I.K., Akushskaya A.S. Study of 
the nomenclature of adaptogenic drugs presented on 
the pharmaceutical market of the Russian Federation 
fundamental research No. 8, 2014, pp. 898-902 

H. K. Bekchanov, kh. J. Kambarov, l. M. Jalilov, kh. M. 
Djalilova, l. S’h. Yakubova, j. S’h. S’hoymurodov. 
Development of the composite a\d technology of 
capsules of the medicinal preparation containing the 
dry yextract “s’harq tab1bi” journal of human 
university, (natural sciences) vol. 48. No. 8. August 
2021, 176-185. 

Evolution of the adaptogenic concept from traditional 
use to medical systems: pharmacology of stress- and 
ging-related diseases. Review a r t i c l e 
wileyonlinelibrary.com/journal/med med res rev. 
2021; 41:630–703. 

State Register of Medicines and Medical Devices 
Registered in the Republic of Uzbekistan - No. 25 of 
2021. 

 


